Novavax Management

Management criteria checks 1/4

Key information

John Jacobs

Chief executive officer


Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure2.3yrs
Board average tenure2.8yrs

Recent management updates

Recent updates

Time To Worry? Analysts Just Downgraded Their Novavax, Inc. (NASDAQ:NVAX) Outlook

Mar 05
Time To Worry? Analysts Just Downgraded Their Novavax, Inc. (NASDAQ:NVAX) Outlook

COVID-19 remains global health emergency - WHO

Oct 19

Novavax spikes ahead of presentations on COVID-19 vaccine portfolio

Oct 10

US Supreme Court declines to hear challenge of COVID vaccine mandate for health workers

Oct 03

Novavax makes 1M doses of its COVID-19 vaccine available for use in the UK

Sep 27

EU clears Novavax's COVID-19 shot for use as a booster dose in adults

Sep 12

Novavax wins EU backing for COVID-19 booster shot

Sep 01

Novavax: Finding Its Niche

Aug 23

Novavax COVID vaccine gets provisional approval in New Zealand as booster shot

Aug 17

Novavax Q2: Time To Turn Bullish After The Massive Collapse

Aug 11

Bearish: Analysts Just Cut Their Novavax, Inc. (NASDAQ:NVAX) Revenue and EPS estimates

Aug 11
Bearish: Analysts Just Cut Their Novavax, Inc. (NASDAQ:NVAX) Revenue and EPS estimates

Novavax COVID-19 shot is linked to rare cases of heart inflammation – EU agency

Aug 03

Novavax gets Japanese regulatory nod for use of its COVID vaccine in teens

Jul 26

Serum Institute of India supplies Novavax's COVID vaccine in US

Jul 18

Novavax to deliver 3.2M doses of COVID-19 vaccine to U.S.

Jul 11

Novavax wins EU nod to use COVID-19 vaccine in adolescents

Jul 05

Taiwan to get 504K doses of Novavax COVID vaccine in 1st lot this week

Jun 29

Novavax seeks label expansion for COVID-19 shot in Canada

Jun 23

The Novavax Vaccine, Finally

Jun 08

Is Novavax (NASDAQ:NVAX) Using Debt In A Risky Way?

May 24
Is Novavax (NASDAQ:NVAX) Using Debt In A Risky Way?

Novavax: Buying Here Will Not End Well

May 18

Novavax: Don't Catch The Falling Knives

May 07

Novavax: Management's Revenue Guidance - If It Can Be Trusted - Makes The Bull Case

Apr 21


John Jacobs (55 yo)

less than a year


Mr. John Charles Jacobs, M.B.A., serves as President, Chief Executive Officer and Director of Novavax, Inc. since January 23, 2023. He was Director of Life Sciences Pennsylvania from May 06, 2021 until Jan...

Leadership Team

James Kelly
Executive VP1.8yrsUS$3.08m0.0039%
$ 24.2k
John Herrmann
Executive VP & Chief Legal Officer11.2yrsUS$3.10m0.017%
$ 105.7k
Stanley Erck
Advisorless than a yearUS$8.40m0.042%
$ 263.1k
John Trizzino
Executive VP1.8yrsUS$3.08m0.011%
$ 65.3k
John Jacobs
Presidentless than a yearno datano data
Richard Crowley
Executive VP & COO2.4yrsno datano data
Gale Smith
Senior VP of Discovery & Pre-Clinical Research and Chief Scientist2.1yrsUS$489.25kno data
Biegie Lee
Senior VP & Chief Information Officer2.5yrsno datano data
Troy Morgan
Senior VP & Chief Compliance Officer2.1yrsno datano data
Erika Trahan
Associate Director of Investor & Public Relations5.1yrsno datano data
Sven Andreasson
Senior Vice President of Corporate Development8.9yrsno datano data
Frank Czworka
Senior Vice President of Global Sales2.8yrsno datano data


Average Tenure


Average Age

Experienced Management: NVAX's management team is considered experienced (2.3 years average tenure).

Board Members

John Jacobs
Presidentless than a yearno datano data
David Mott
Independent Director2.9yrsUS$380.56k0.051%
$ 315.8k
Richard Douglas
Independent Director13.3yrsUS$382.56k0.043%
$ 268.6k
Margaret McGlynn
Independent Director2.4yrsUS$369.17k0.0044%
$ 27.4k
Gregg Alton
Independent Director2.6yrsUS$378.06k0.0044%
$ 27.4k
Rachel King
Independent Director4.5yrsUS$368.54k0.014%
$ 88.3k
Richard Rodgers
Independent Directorless than a yearUS$639.51kno data
James Young
Independent Chairman of the Board13.1yrsUS$561.55k0.081%
$ 505.3k


Average Tenure


Average Age

Experienced Board: NVAX's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.